Chemours Co (CC)
Days of sales outstanding (DSO)
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Receivables turnover | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| DSO | days | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
December 31, 2024 calculation
DSO = 365 ÷ Receivables turnover
= 365 ÷ —
= —
The days of sales outstanding (DSO) for Chemours Co is not provided for the periods from March 31, 2020, to December 31, 2024. As a result, it is not possible to analyze the trend or assess the efficiency of the company's accounts receivable management based on this ratio. DSO is a measure of how efficiently a company is collecting its accounts receivable, and a lower DSO indicates that the company is collecting payments from its customers more quickly.
Without specific DSO data, it is challenging to evaluate the company's performance in managing its accounts receivable turnover and the effectiveness of its credit and collection policies. DSO analysis is crucial for understanding the liquidity and cash flow impacts of accounts receivable on the business operations. Going forward, it would be beneficial for stakeholders and analysts to have access to this information to gain insights into Chemours Co's working capital management and overall financial health.
Peer comparison
Dec 31, 2024